Transcatheter treatment for tricuspid valve disease.

Volume: 17, Issue: 10, Pages: 791 - 808
Published: Nov 19, 2021
Abstract
Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve apparatus and is observed in only 8-10% of the patients with tricuspid valve disease. Secondary TR is more common and arises as a result of annular dilation caused by right ventricular enlargement and dysfunction as a consequence of pulmonary hypertension, often caused by...
Paper Details
Title
Transcatheter treatment for tricuspid valve disease.
Published Date
Nov 19, 2021
Volume
17
Issue
10
Pages
791 - 808
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.